187 related articles for article (PubMed ID: 19702693)
1. Pharmacogenetic of response efficacy to antipsychotics in schizophrenia: pharmacodynamic aspects. Review and implications for clinical research.
Blanc O; Brousse G; Meary A; Leboyer M; Llorca PM
Fundam Clin Pharmacol; 2010 Apr; 24(2):139-60. PubMed ID: 19702693
[TBL] [Abstract][Full Text] [Related]
2. [Receptor polymorphism and response to treatment in schizophrenia].
Szekeres G; Janka Z
Orv Hetil; 2002 Sep; 143(35):2027-33. PubMed ID: 12387196
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
Arranz MJ; de Leon J
Mol Psychiatry; 2007 Aug; 12(8):707-47. PubMed ID: 17549063
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics of antipsychoatics.
Ozaki N
Nagoya J Med Sci; 2004 May; 67(1-2):1-7. PubMed ID: 15279062
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics and schizophrenia.
Foster A; Miller DD; Buckley PF
Psychiatr Clin North Am; 2007 Sep; 30(3):417-35. PubMed ID: 17720030
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacogenetics and tailored drug treatment in schizophrenia].
Andreassen OA; Steen VM
Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2400-2. PubMed ID: 16998555
[TBL] [Abstract][Full Text] [Related]
7. The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia.
Hamdani N; Tabeze JP; Ramoz N; Ades J; Hamon M; Sarfati Y; Boni C; Gorwood P
Eur Neuropsychopharmacol; 2008 Jan; 18(1):34-40. PubMed ID: 17669634
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacogenetics and treatment response in schizophrenia].
Moulier V; Januel D
Encephale; 2007 Dec; 33(6):954-64. PubMed ID: 18789788
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics of dopamine receptors and response to antipsychotic drugs in schizophrenia--an update.
Scharfetter J
Pharmacogenomics; 2004 Sep; 5(6):691-8. PubMed ID: 15335289
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetic studies of response to risperidone and other newer atypical antipsychotics.
Lane HY; Lee CC; Liu YC; Chang WH
Pharmacogenomics; 2005 Mar; 6(2):139-49. PubMed ID: 15882132
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of antipsychotic treatment in schizophrenia.
Pouget JG; Müller DJ
Methods Mol Biol; 2014; 1175():557-87. PubMed ID: 25150876
[TBL] [Abstract][Full Text] [Related]
12. The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment.
Reynolds GP; Templeman LA; Zhang ZJ
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1021-8. PubMed ID: 15953671
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetic approaches to cognitive enhancement in schizophrenia.
Burdick KE; Gopin CB; Malhotra AK
Harv Rev Psychiatry; 2011; 19(3):102-8. PubMed ID: 21631157
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomics of antipsychotics efficacy for schizophrenia.
Cacabelos R; Hashimoto R; Takeda M
Psychiatry Clin Neurosci; 2011 Feb; 65(1):3-19. PubMed ID: 21265934
[TBL] [Abstract][Full Text] [Related]
15. Association study between antipsychotics- induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia.
Kang SG; Lee HJ; Choi JE; Park YM; Park JH; Han C; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
Neuropsychobiology; 2008; 57(1-2):49-54. PubMed ID: 18451638
[TBL] [Abstract][Full Text] [Related]
16. Toward understanding genetic risk for differential antipsychotic response in individuals with schizophrenia.
Arranz MJ; Munro JC
Expert Rev Clin Pharmacol; 2011 May; 4(3):389-405. PubMed ID: 22114782
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacogenetics of antipsychotics in schizophrenia].
Méary A
Therapie; 2008; 63(3):243-6. PubMed ID: 18718213
[TBL] [Abstract][Full Text] [Related]
18. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.
Basile VS; Masellis M; McIntyre RS; Meltzer HY; Lieberman JA; Kennedy JL
J Clin Psychiatry; 2001; 62 Suppl 23():45-66. PubMed ID: 11603885
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetics. Promise and potential in child and adolescent psychiatry.
Anderson GM; Cook EH
Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):23-42, viii. PubMed ID: 10674189
[TBL] [Abstract][Full Text] [Related]
20. [Clinical pharmacogenetics in the treatment of schizophrenia].
Saito M; Yasui-Furukori N; Kaneko S
Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Jun; 25(3):129-35. PubMed ID: 16045195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
